HEALEY ALS Platform Trial - Master Protocol

NCT04297683 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Zilucoplan
DRUG: Verdiperstat
DRUG: CNM-Au8
DRUG: Pridopidine
DRUG: SLS-005 Trehalose
DRUG: ABBV-CLS-7262
DRUG: DNL343
DRUG: NUZ-001

Sponsor

Merit E. Cudkowicz, MD

Collaborators

[object Object]